Cell Sorting Market Size, Share & Trends Analysis Report By Product (Cell Sorters, Reagents & Consumables), By Technology, By Application (Research, Clinical), By End Use, By Region, And Segment Forecasts, 2025 - 2033GVR-3-68038-990-6
Description
Cell Sorting Market Summary
The global cell sorting market size was estimated at USD 261.1 million in 2024 and is projected to reach USD 569.1 million by 2033, growing at a CAGR of 9.19% from 2025 to 2033. The industry has witnessed significant advancements, driven by innovations such as high-speed sorting and advanced detection capabilities, which enhance precision and efficiency.
Technological Innovations
The market for cell sorting has grown significantly due to technological advancements. The reliability of sorting results has been further improved by automation, software integration, and instrument sensitivity advancements, opening these technologies to a greater variety of labs and clinical settings. Because of this, adoption rates have increased for therapeutic and research applications, which has fueled market expansion. These advancements have made cell sorting tools essential in various fields, including research and clinical applications. Fluorescence-Activated Cell Sorting (FACS), in particular, is a significant contributor to the market’s growth due to its ability to provide quick and quantitative measurements of cell properties, making it an essential tool for sorting heterogeneous cell populations.
Moreover, its integration with proteomics, genomics, and high-throughput screening platforms has greatly expanded cell sorting's market potential and usefulness. The global cell sorting market is experiencing sustained demand due to the new opportunities this convergence of technologies brings to academic, clinical, and industrial users.
Global Cell Sorting Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell sorting market on the basis of product, technology, application, end use, and region.
The global cell sorting market size was estimated at USD 261.1 million in 2024 and is projected to reach USD 569.1 million by 2033, growing at a CAGR of 9.19% from 2025 to 2033. The industry has witnessed significant advancements, driven by innovations such as high-speed sorting and advanced detection capabilities, which enhance precision and efficiency.
Technological Innovations
The market for cell sorting has grown significantly due to technological advancements. The reliability of sorting results has been further improved by automation, software integration, and instrument sensitivity advancements, opening these technologies to a greater variety of labs and clinical settings. Because of this, adoption rates have increased for therapeutic and research applications, which has fueled market expansion. These advancements have made cell sorting tools essential in various fields, including research and clinical applications. Fluorescence-Activated Cell Sorting (FACS), in particular, is a significant contributor to the market’s growth due to its ability to provide quick and quantitative measurements of cell properties, making it an essential tool for sorting heterogeneous cell populations.
Moreover, its integration with proteomics, genomics, and high-throughput screening platforms has greatly expanded cell sorting's market potential and usefulness. The global cell sorting market is experiencing sustained demand due to the new opportunities this convergence of technologies brings to academic, clinical, and industrial users.
Global Cell Sorting Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell sorting market on the basis of product, technology, application, end use, and region.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Cell Sorters
- Reagents and Consumables
- Services
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Fluorescence-based Droplet Cell Sorting
- Jet-in-air Cell Sorting
- Cuvette-based Cell Sorting
- Magnetic-activated Cell Sorting
- MEMS - Microfluidics
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Research Applications
- Immunology & Cancer Research
- Stem Cell Research
- Drug Discovery
- Other Research Applications
- Clinical Applications
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Research Institutions
- Medical Schools and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinical Testing Laboratories
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Impact Analysis
- 3.3.1.1. Technology innovations
- 3.3.1.2. Increasing clinical applications
- 3.3.2. Market Restraint Impact Analysis
- 3.3.2.1. High cost of instruments and consumables
- 3.3.2.2. Technical complexity and requirement for skilled personnel
- 3.4. Business Environment Analysis
- 3.4.1. PESTLE Analysis
- 3.4.2. PORTER’S Five Forces Analysis
- Chapter 4. Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Cell Sorting Market Product, Movement Analysis
- 4.3. Global Cell Sorting Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Cell Sorters
- 4.4.1. Global cell sorters market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Reagents and Consumables
- 4.5.1. Global reagents and consumables market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Services
- 4.6.1. Global services market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Technology Business Analysis
- 5.1. Technology Segment Dashboard
- 5.2. Global Cell Sorting Market Technology, Movement Analysis
- 5.3. Global Cell Sorting Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
- 5.4. Fluorescence-based Droplet Cell Sorting
- 5.4.1. Global fluorescence-based droplet cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.1.1. Jet-in-air Cell Sorting
- 5.4.1.1.1. Global jet-in-air cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.1.2. Cuvette-based Cell Sorting
- 5.4.1.2.1. Global cuvette-based cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. Magnetic-activated Cell Sorting
- 5.5.1. Global magnetic-activated cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6. MEMS - Microfluidics
- 5.6.1. Global MEMS - microfluidics cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global Cell Sorting Market Application, Movement Analysis
- 6.3. Global Cell Sorting Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Research Applications
- 6.4.1. Global research applications cell sorting market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.1.1. Immunology & Cancer Research
- 6.4.1.1.1. Global immunology & cancer research market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.1.2. Stem Cell Research
- 6.4.1.2.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.1.3. Drug Discovery
- 6.4.1.3.1. Global drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4.1.4. Other Research Applications
- 6.4.1.4.1. Global other research applications market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Clinical Applications
- 6.5.1. Global clinical applications market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 7. End Use Business Analysis
- 7.1. End Use Segment Dashboard
- 7.2. Global Cell Sorting Market End Use, Movement Analysis
- 7.3. Global Cell Sorting Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Research Institutions
- 7.4.1. Global research institutions companies market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Medical Schools and Academic Institutions
- 7.5.1. Global medical schools and academic institutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Pharmaceutical and Biotechnology Companies
- 7.6.1. Global pharmaceutical and biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. Hospitals and Clinical Testing Laboratories
- 7.7.1. Global hospitals and clinical testing laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Cell Sorting Market: Regional Estimates and Trend Analysis, by Product, Technology, Application, & End use
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 8.3. North America
- 8.3.1. North America cell sorting market, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Target Disease Prevalence
- 8.3.2.3. Competitive Scenario
- 8.3.2.4. Regulatory Framework
- 8.3.2.5. U.S. cell sorting market, 2021 - 2033 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Target Disease Prevalence
- 8.3.3.3. Competitive Scenario
- 8.3.3.4. Regulatory Framework
- 8.3.3.5. Canada cell sorting market, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Target Disease Prevalence
- 8.3.4.3. Competitive Scenario
- 8.3.4.4. Regulatory Framework
- 8.3.4.5. Mexcio cell sorting market, 2021 - 2033 (USD Million)
- 8.4. Europe
- 8.4.1. Europe cell sorting market, 2021 - 2033 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Target Disease Prevalence
- 8.4.2.3. Competitive Scenario
- 8.4.2.4. Regulatory Framework
- 8.4.2.5. UK cell sorting market, 2021 - 2033 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Target Disease Prevalence
- 8.4.3.3. Competitive Scenario
- 8.4.3.4. Regulatory Framework
- 8.4.3.5. Germany cell sorting market, 2021 - 2033 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Target Disease Prevalence
- 8.4.4.3. Competitive Scenario
- 8.4.4.4. Regulatory Framework
- 8.4.4.5. France cell sorting market, 2021 - 2033 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Target Disease Prevalence
- 8.4.5.3. Competitive Scenario
- 8.4.5.4. Regulatory Framework
- 8.4.5.5. Italy cell sorting market, 2021 - 2033 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Target Disease Prevalence
- 8.4.6.3. Competitive Scenario
- 8.4.6.4. Regulatory Framework
- 8.4.6.5. Spain cell sorting market, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Target Disease Prevalence
- 8.4.7.3. Competitive Scenario
- 8.4.7.4. Regulatory Framework
- 8.4.7.5. Denmark cell sorting market, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Target Disease Prevalence
- 8.4.8.3. Competitive Scenario
- 8.4.8.4. Regulatory Framework
- 8.4.8.5. Sweden cell sorting market, 2021 - 2033 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Target Disease Prevalence
- 8.4.9.3. Competitive Scenario
- 8.4.9.4. Regulatory Framework
- 8.4.9.5. Norway cell sorting market, 2021 - 2033 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific cell sorting market, 2021 - 2033 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Target Disease Prevalence
- 8.5.2.3. Competitive Scenario
- 8.5.2.4. Regulatory Framework
- 8.5.2.5. Japan cell sorting market, 2021 - 2033 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Target Disease Prevalence
- 8.5.3.3. Competitive Scenario
- 8.5.3.4. Regulatory Framework
- 8.5.3.5. China cell sorting market, 2021 - 2033 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Target Disease Prevalence
- 8.5.4.3. Competitive Scenario
- 8.5.4.4. Regulatory Framework
- 8.5.4.5. India cell sorting market, 2021 - 2033 (USD Million)
- 8.5.5. Singapore
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Target Disease Prevalence
- 8.5.5.3. Competitive Scenario
- 8.5.5.4. Regulatory Framework
- 8.5.5.5. Singapore cell sorting market, 2021 - 2033 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Target Disease Prevalence
- 8.5.6.3. Competitive Scenario
- 8.5.6.4. Regulatory Framework
- 8.5.6.5. Australia cell sorting market, 2021 - 2033 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Target Disease Prevalence
- 8.5.7.3. Competitive Scenario
- 8.5.7.4. Regulatory Framework
- 8.5.7.5. Thailand cell sorting market, 2021 - 2033 (USD Million)
- 8.5.8. South Korea
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Target Disease Prevalence
- 8.5.8.3. Competitive Scenario
- 8.5.8.4. Regulatory Framework
- 8.5.8.5. South Korea cell sorting market, 2021 - 2033 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America cell sorting market, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Target Disease Prevalence
- 8.6.2.3. Competitive Scenario
- 8.6.2.4. Regulatory Framework
- 8.6.2.5. Brazil cell sorting market, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Target Disease Prevalence
- 8.6.3.3. Competitive Scenario
- 8.6.3.4. Regulatory Framework
- 8.6.3.5. Argentina cell sorting market, 2021 - 2033 (USD Million)
- 8.7. MEA
- 8.7.1. MEA cell sorting market, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Target Disease Prevalence
- 8.7.2.3. Competitive Scenario
- 8.7.2.4. Regulatory Framework
- 8.7.2.5. South Africa cell sorting market, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Target Disease Prevalence
- 8.7.3.3. Competitive Scenario
- 8.7.3.4. Regulatory Framework
- 8.7.3.5. Saudi Arabia cell sorting market, 2021 - 2033 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Target Disease Prevalence
- 8.7.4.3. Competitive Scenario
- 8.7.4.4. Regulatory Framework
- 8.7.4.5. UAE cell sorting market, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Target Disease Prevalence
- 8.7.5.3. Competitive Scenario
- 8.7.5.4. Regulatory Framework
- 8.7.5.5. Kuwait cell sorting market, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Market Position Analysis, 2024
- 9.4. Company Profiles/Listing
- 9.4.1. BD
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Bio-Rad Laboratories, Inc.
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Danaher Corporation
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Sony Group Corporation
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Miltenyi Biotec
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. On-chip Biotechnologies Co., Ltd.
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Cytonome/ST, LLC
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Union Biometrica, Inc.
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Thermo Fisher Scientific Inc.
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. uFluidix
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



